JAZZ$214.370.75%-1.61
After Hours: 214.43+0.06 +0.03%
Jazz Pharmaceuticals Plc (JAZZ)
Date: 2026-11-02 16:00O: 215.84H: 218.36L: 213.81C: 214.37Vol: 874.2k
Jazz Pharmaceuticals Plc stock is traded at $214.37, with a volume of 874,152. It is down -0.75% in the last 24 hours and down -9.04% over the past month. Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
Previous Close:
$215.98
Open:
$215.84
24h Volume:
874,152
Relative Volume:
1.07
Market Cap:
$13.92B
Revenue:
$4.44B
Net Income/Loss:
$29.49M
P/E Ratio:
-
EPS:
-$0.0184
Net Cash Flow:
$1.19B
1W Performance:
+4.21%
1M Performance:
-9.04%
6M Performance:
+5.75%
1Y Performance:
+55.75%
1-Day Range:
$213.81$218.36
1-Week Range:
$202.30$218.36
52-Week Range:
$128.80$266.38
Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile
Name
Jazz Pharmaceuticals PlcSector
HealthcareIndustry
BiotechnologyPhone
353-1-634-7800Address
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN, IrelandCompare JAZZ vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|
JAZZ Jazz Pharmaceuticals Plc | $13.92B | $4.72B | $205.95M | $1.62B | -$0.0184 |
 VRTX Vertex Pharmaceuticals Inc | $140.94B | $12.59B | $4.41B | $3.80B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $99.46B | $16.90B | $4.82B | $3.83B | $41.04 |
 MRNA Moderna Inc | $88.17B | $2.23B | -$3.15B | -$1.24B | -$8.15 |
 ARGX Argen X Se Adr | $55.03B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $40.86B | $6.13B | $655.71M | $1.33B | $4.48 |
Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades
Jazz Pharmaceuticals Plc Stock (JAZZ) Financials Data
Jazz Pharmaceuticals Plc Stock (JAZZ) Insider Trading
- Bruce C CozaddNov 02 '26Officer
- Transaction
- Proposed Sale
- Cost
- $215.84
- #Shares
- 6,000
- Value ($)
- 1,295,040
- #Shares Total
- 0
- ANNE O'RIORDANOct 08 '26Director
- Transaction
- Proposed Sale
- Cost
- $228.55
- #Shares
- 14,687
- Value ($)
- 3,356,714
- #Shares Total
- 0
- RENEE D GALAOct 06 '26Officer
- Transaction
- Proposed Sale
- Cost
- $236.40
- #Shares
- 2,000
- Value ($)
- 472,800
- #Shares Total
- 0
- GALA RENEE DOct 06 '26President & CEO
- Transaction
- Sale
- Cost
- $236.40
- #Shares
- 2,000
- Value ($)
- 472,800
- #Shares Total
- 141,394
- COZADD BRUCE COct 01 '26Director
- Transaction
- Sale
- Cost
- $230.33
- #Shares
- 6,000
- Value ($)
- 1,381,980
- #Shares Total
- 345,875
- Bruce C CozaddOct 01 '26Officer
- Transaction
- Proposed Sale
- Cost
- $230.33
- #Shares
- 6,000
- Value ($)
- 1,381,980
- #Shares Total
- 0
- Patil Neena MSep 10 '26EVP & Chief Legal Officer
- Transaction
- Sale
- Cost
- $240.94
- #Shares
- 1,200
- Value ($)
- 289,128
- #Shares Total
- 47,671
- NEENA PATILSep 10 '26Officer
- Transaction
- Proposed Sale
- Cost
- $240.94
- #Shares
- 1,200
- Value ($)
- 289,128
- #Shares Total
- 0
- Henderson Mary ElizabethSep 08 '26Director
- Transaction
- Proposed Sale
- Cost
- $246.81
- #Shares
- 2,691
- Value ($)
- 664,166
- #Shares Total
- 0
- RENEE D GALASep 08 '26Officer
- Transaction
- Proposed Sale
- Cost
- $243.03
- #Shares
- 2,000
- Value ($)
- 486,060
- #Shares Total
- 0
